Found 17 matching trials
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14 PHASE3 Summary
In patients with prostate cancer (PC) who have only biochemically ...
Show More Location
Copenhagen University hospital, Rigshospitalet
Learn More & Join Trial
Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide PHASE2 This study is being conducted to determine the effect of enzalutamide on th...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer PHASE3 RATIONALE: Antiandrogen withdrawal may be an effective treatment for prosta...
Show More Location
UCSF Cancer Center and Cancer Research Institute
Learn More & Join Trial
A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC) PHASE3 The purpose of this study is to determine if newly diagnosed (within previo...
Show More Location
Multiple Locations
Learn More & Join Trial
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients PHASE4 Androgen deprivation therapy (ADT) is a mainstay of prostate cancer treatme...
Show More Location
Department of Urology, Chungbuk National University, College of Medicine
Learn More & Join Trial
Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer PHASE2 GUARD-QUANTUM is a prospective, phase II, single-arm, non-randomized, non-b...
Show More Location
Hospital Clínic de Barcelona
Learn More & Join Trial
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients N/A In this observational study, blood samples for pharmacokinetic (PK) testing...
Show More Location
UPMC CancerCenter - Beaver
Learn More & Join Trial
Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy PHASE2 The purpose of this study is to evaluate the efficacy, based on prostate-sp...
Show More Location
Multiple Locations
Learn More & Join Trial
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer PHASE3 The purpose of this study is to determine the benefit of enzalutamide versu...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases. PHASE2 Open-label phase II multi-centre single arm study of Denosumab in combinati...
Show More Location
Galway University Hospital
Learn More & Join Trial